| Business Summary | | Thermo
Electron
Corporation
is
engaged
in
the
development,
manufacture
and
sale
of
technology-based
instrument
systems,
components
and
solutions
used
in
virtually
every
industry
to
monitor,
collect
and
analyze
data
to
provide
knowledge
for
the
user.
Its
analysis
technologies
help
biotech
researchers
sift
through
data
to
make
the
discoveries
that
will
fight
disease
or
prolong
life,
allow
telecommunication
equipment
manufacturers
to
fabricate
components
required
to
increase
the
speed
and
quality
of
communications
and
monitor
and
control
industrial
processes
online
to
ensure
that
critical
quality
standards
are
met
efficiently
and
safely.
The
Company's
continuing
operations
fall
into
three
business
segments,
Life
Sciences,
Optical
Technologies
and
Measurement
and
Control. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | Thermo
Electron
provides
technology-based
instruments,
components,
and
systems
that
offer
solutions
for
markets
ranging
from
life
sciences
to
telecommunications
to
food,
drug
and
beverage
production.
For
the
26
weeks
ended
6/30/01,
revenues
fell
4%
to
$1.12
billion.
Net
income
from
continuing
operations
before
extraordinary
item
and
acct.
change
fell
14%
to
$31.2
million.
Results
reflect
the
effects
of
divested
operations,
foreign
currency
fluctuations,
and
$37
million
in
restructuring
charges. | More
from
Market Guide: Significant
Developments |
| | | | FY2000
Compensation | | Pay | Exer | |
| Richard Syron, 57 Chairman,
CEO | $3.6M | -- | Marijn Dekkers, 43 Pres,
COO, Director | -- | -- | Theo Melas-Kyriazi, 41 CFO
and VP | 1.1M | $101K | Seth Hoogasian, 46 VP,
Gen. Counsel | -- | -- | Stephen Sheehan, 45 VP
of HR | -- | -- | Dollar
amounts are as of 30-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.; "Exer" is the value of options excercised during the fiscal year. |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|